- Home
- DERM vs INO Comparison
DERM vs INO Comparison
Compare DERM & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DERM
- INO
- Stock Information
- Founded
- DERM 2014
- INO 1979
- Country
- DERM United States
- INO United States
- Employees
- DERM N/A
- INO N/A
- Industry
- DERM Biotechnology: Pharmaceutical Preparations
- INO Medical/Dental Instruments
- Sector
- DERM Health Care
- INO Health Care
- Exchange
- DERM Nasdaq
- INO Nasdaq
- Market Cap
- DERM 87.4M
- INO 75.4M
- IPO Year
- DERM 2021
- INO 1998
- Fundamental
- Price
- DERM $3.74
- INO $2.20
- Analyst Decision
- DERM Strong Buy
- INO Buy
- Analyst Count
- DERM 3
- INO 6
- Target Price
- DERM $9.50
- INO $17.00
- AVG Volume (30 Days)
- DERM 61.7K
- INO 1.2M
- Earning Date
- DERM 11-12-2024
- INO 03-05-2025
- Dividend Yield
- DERM N/A
- INO N/A
- EPS Growth
- DERM N/A
- INO N/A
- EPS
- DERM N/A
- INO N/A
- Revenue
- DERM $57,771,000.00
- INO $203,413.00
- Revenue This Year
- DERM N/A
- INO N/A
- Revenue Next Year
- DERM $36.49
- INO $1,970.14
- P/E Ratio
- DERM N/A
- INO N/A
- Revenue Growth
- DERM N/A
- INO N/A
- 52 Week Low
- DERM $2.85
- INO $1.74
- 52 Week High
- DERM $6.89
- INO $14.75
- Technical
- Relative Strength Index (RSI)
- DERM 32.80
- INO 44.04
- Support Level
- DERM $3.54
- INO $1.83
- Resistance Level
- DERM $3.99
- INO $2.39
- Average True Range (ATR)
- DERM 0.35
- INO 0.18
- MACD
- DERM 0.00
- INO 0.12
- Stochastic Oscillator
- DERM 21.28
- INO 70.31
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.